BIO 2017: Biopharma industry must target unpopularity, says Allergan CEO

20-06-2017

BIO 2017: Biopharma industry must target unpopularity, says Allergan CEO

brauns / iStockphoto.com

The biopharma industry must do its part in changing the public's view of the sector, because the political reality is that it is unpopular, according to Brent Saunders, chairman, president and CEO of Allergan.


Allergan, Brent Saunders, biopharma, BIO 2017, research and development, R&D, treatments, pricing

LSIPR